XERS News and Press, Xeris Pharmaceuticals Inc. From 12/11/20

The European Medicines Agency's advisory group CHMP has adopted a positive opinion for Xeris Pharmaceuticals' (XERS) Ogluo (glucagon) recommending Ogluo for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The Europe...

Positive CHMP Opinion based on data from a multi-center, randomized Phase 3 trial Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use (RTU) injectab...

Last year, I was neutral about the Xeris Pharmaceuticals story; but a lot of positives have happened this year. There's a marketed product, a steadily rising revenue stream, a platform with potential, and George Soros recently purchased a 5% stake. Xeris looks a lot more enticing ...

Image source: The Motley Fool. Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Q3 2020 Earnings Call Nov 9, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: Xeris Pharmaceuticals, Inc. (XERS) Q3 2020 Earnings Call Transcr...

Xeris Pharmaceuticals, Inc. (XERS) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations and Corporate Communication Paul Edick - Chairman and Chief Executive Officer Barry Deutsch - Chief Financial Officer ...

Xeris Pharmaceuticals (XERS): Q3 GAAP EPS of -$0.35 beats by $0.19.Revenue of $9.4M beats by $4.92M.Shares +4.6% PM.Press Release For further details see: Xeris Pharmaceuticals EPS beats by $0.19, beats on revenue

Gvoke® net sales grew 370% quarter over quarter to $9.4 million driven by launch of Gvoke HypoPen® Company to host a conference call and webcast today at 8:30 a.m. ET Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging ...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the Company will release its third quarter 2020...

Astrotech Corporation (ASTC) +145% in reaction to its partnership with Cleveland Clinic.Marin Software (MRIN) +138%.NetSol Technologies (NTWK) +67% after its platform goes live in China.VOC Energy Trust (VOC) +27%.Greenpro Capital (GRNQ) +13%.Snap (SNAP) +22% on ...

The FDA has designated Xeris Pharmaceuticals's (XERS) XP-0863 (diazepam non-aqueous injection) for fast track review for the treatment of acute repetitive seizures.XP-0863 was previously granted orphan designations both for the treatment of acute repetitive seizures and for the treatment of D...